The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Surushkina S.Yu.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Chutko L.S.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Pharmacotherapy and psychotherapy of children with attention deficit hyperactivity disorder

Authors:

Surushkina S.Yu., Chutko L.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(2): 21‑25

DOI: 10.17116/jnevro202312302121

Views: 6002

Downloaded: 202

Download PDF (RU)
Contact the author
Table of contents

PHARMACOTHERAPY AND PSYCHOTHERAPY OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
PHARMACOTHERAPY AND PSYCHOTHERAPY OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

To cite this article:

Surushkina SYu, Chutko LS. Pharmacotherapy and psychotherapy of children with attention deficit hyperactivity disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(2):21‑25. (In Russ.)
https://doi.org/10.17116/jnevro202312302121

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Anxiety diso­rders as como­rbid conditions in neuropsychiatric diseases in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):56-64
Neuprotection of post-acute COVID-19 cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):106-111
Post-stroke cognitive impairment in young patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):92-96
Evaluation of the effe­ctiveness of the drug Cortexin in combination with the use of the application Apha­sia.No (Afaziyam.Net) in the correction of speech diso­rders in patients with cere­bral infa­rction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):147-151
The effe­ctiveness of reha­bilitation measures using the drug Cortexin in children with neuropsychiatric pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):86-92
The role of gene­tic poly­morphisms in folate meta­bolism genes in the mani­festation of migraine in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):47-52
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
The possibility of using neurotropic therapy in patients with persistent postural-perceptual dizziness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):89-94

The article presents a review of scientific publications devoted to the main psychotherapeutic approaches that have shown their effectiveness in correcting behavior in children with attention-deficit/hyperactive disorder (ADHD). The principles of psychotherapeutic methods are outlined to reduce the severity of the main symptoms of ADHD and improve the social adaptation of children with this disease. Approaches to the drug therapy of ADHD and the results of studies on the effectiveness of various drugs used to treat this pathology are considered.

Keywords:

attention deficit hyperactivity disorder
psychotherapeutic correction
cortexin
atomoxetine

Authors:

Surushkina S.Yu.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Chutko L.S.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Received:

31.01.2023

Accepted:

01.02.2023

List of references:

  1. Mesh E, Vol’f D. Abnormal child psychology. Per. s angl. SPb.: Praim-Evroznak; 2003. (In Russ).
  2. Monina GB, Lyutova-Roberts EK, Chutko LS. Giperaktivnye deti: psikhologo-pedagogicheskaya pomoshch’. Monografiya. SPb.: Rech’; 2007. (In Russ).
  3. Barkley R.A. Defiant children. Aclinician’s Manuel for assessment and Parent training. NY. 2009.
  4. Kvashner K, Remshmidt Kh. Giperkineticheskie rasstroistva. Detskaya i podrostkovaya psikhiatriya. M.: Eksmo-Press; 2001;203-207. (In Russ).
  5. Faifer L, Krauder A, Elsenraat T, Gall R. CBT Toolbox for Children and Adolescents: Over 200 Worksheets & Exercises for Trauma, ADHD, Autism, Anxiety, Depression & Conduct Disorders. SPb.: Dialektika; 2017. (In Russ).
  6. Pfiffner LJ, Haack LM. Behavior management for school-aged children with ADHD. Child Adolesc Psychiatr Clin N Am. 2014;23(4):731-746.  https://doi.org/10.1016/j.chc.2014.05.014
  7. Wolraich ML, Hagan JF, Allan C. AAP subcommittee on children and adolescents with attention-deficit/hyperactive disorder. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit. Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e2019252.
  8. Hornstra R, van der Oord S, Staff AI, et al. Which Techniques Work in Behavioral Parent Training for Children with ADHD? A Randomized Controlled Microtrial. J Clin Child Adolesc Psychol. 2021;50(6):888-903.  https://doi.org/10.1080/15374416.2021.1955368
  9. Daley D, van der Oord S, Ferrin M, et al. Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. J Am Acad Child Adolesc Psychiatry. 2014;53(8):835-847.  https://doi.org/10.1016/j.jaac.2014.05.013
  10. Sprich S, Safren S, Finkelstein D, Remmert J, Hammerness P. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016;57(11):1218-1226. https://doi.org/10.1111/jcpp.12549
  11. Sciberras E, Efron D, Patel P, et al. Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial. BMC Psychiatry. 2019;19(1):359.  https://doi.org/10.1186/s12888-019-2276-3
  12. Lambez B, Harwood-Gross A, Golumbic EZ, Rassovsky Y. Non-pharmacological interventions for cognitive difficulties in ADHD: A systematic review and meta-analysis. J Psychiatr Res. 2020;120:40-55.  https://doi.org/10.1016/j.jpsychires.2019.10.007
  13. Drechsler R, Rizzo P, Steinhausen HC. The impact of instruction and response cost on the modulation of response-style in children with ADHD. Behav Brain Funct. 2010;6:31.  https://doi.org/10.1186/1744-9081-6-31
  14. Shevchenko YuS. Klinicheskaya psikhoterapiya (instinktivno-povedencheskie i neiropsikhologicheskie modeli). MIA izd.; 2018. (In Russ).
  15. Prashko Ya, Mozhny P, Shlepetski M. Cognitive-behavioral therapy of mental disorders. M.: IOI; 2015. (In Russ).
  16. Chan SK, Zhang D, Bögels S, et al. Effects of a mindfulness-based intervention (MYmind) for children with ADHD and their parents: protocol for a randomized controlled trial. BMJ Open. 2018;8(11):e022514. https://doi.org/10.1136/bmjopen-2018-022514
  17. Pugovkina OD, Shil’nikova ZN. The concept of mindfulness: nonspecific factor of psychological wellbeing. [Elektronnyi resurs]. Journal of Modern Foreign Psychology. 2014;3(2):18-28. (In Russ). https://psyjournals.ru/jmfp/2014/n2/70100.shtml
  18. Creswell JD. Mindfulness Interventions. Annu Rev Psychol. 2017;68:491-516.  https://doi.org/10.1146/annurev-psych-042716-051139
  19. Cairncross M, Miller CJ. The effectiveness of mindfulness-based therapies for ADHD: A meta-analytic review. J Atten Disord. 2016;20:1-17.  https://doi.org/10.1177/1087054715625301
  20. Santonastaso O, Zaccari V, Crescentini C, et al. Clinical Application of Mindfulness-Oriented Meditation: A Preliminary Study in Children with ADHD. Int J Environ Res Public Health. 2020;17(18):6916. https://doi.org/10.3390/ijerph17186916
  21. Coghill D, Banaschewski T, Cortese S, et al. The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry. 2021;22:1-25.  https://doi.org/10.1007/s00787-021-01871-x
  22. Espadas M, Insa I, Chamorro M, Alda-Diez JA. Efectos secundarios del metilfenidato en poblacion infantil y juvenil [Side effects of methylphenidate in children and the young]. Rev Neurol. 2018;66(5):157-162. 
  23. Zavadenko NN. Sindrom defitsita vnimaniya s giperaktivnost’yu. V kn. Federal’noe rukovodstvo po detskoi nevrologii. M.: OOO «MK»; 2016;204-212. (In Russ).
  24. Zavadenko NN, Suvorinova NYu, Zavadenko AN. Attention deficit disorder with hyperactivity children and adolescents: possibilities of modern therapy. Voprosy Prakticheskoi Pediatrii. 2018;13(2):11-18. (In Russ). https://doi.org/10.20953/1817-7646-2018-2-11-18
  25. Sukhotina NK, Egorova TI, Konovalova VV, et al. Ispol’zovanie otsenochnykh shkal v kachestve kriteriya effektivnosti lecheniya giperkineticheskikh rasstroistv preparatami neirometabolicheskogo deistviya. Metodicheskie rekomendatsii. M. 2012. (In Russ).
  26. Kupriyanova TA., Koren’ EV. Modern approaches to the treatment of hyperkinetic behavioral disorder. Voprosy Psikhicheskogo Zdorov’ya Detei i Podrostkov. 2018;18(2):35-41. (In Russ).
  27. Chutko LS. Sindrom defitsita vnimaniya s giperaktivnost’yu i soputstvuyushchie rasstroistva. SPb.: Khoka; 2007. (In Russ).
  28. Shapkin AG, Goloborod’ko MV, Berdennikova VV. Efficiency of Cortexin in the treatment of attention deficit hyperactivity disorder according to electroencephalographic study data. Pediatriya. Prilozhenie k zhurnalu Consilium Medicum. 2009;2:41-45. (In Russ).
  29. Chutko LS, Surushkina SYu. Modern approaches to the treatment and rehabilitation of children with ADHD. Detskaya i Podrostkovaya Reabilitatsiya. 2014;1(22):35-41. (In Russ).
  30. Zykov VP, Serebrennikova EB, Panchenko TN, et al. Results of a multicenter study on the efficacy of cortexin in treatment of cognitive dysfunction in children. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(3):27-31. (In Russ.). https://doi.org/10.17116/jnevro20181183127-31
  31. Barton J. Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child. 2005;90(suppl 1):26-29.  https://doi.org/10.1136/adc.2004.059386
  32. Clemow DB, Bushe C, Mancini M, et al. A review of the effcacy of atomoxetine in the treatment of attention-defcit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatmen. 2017;13:357-371.  https://doi.org/10.2147/NDT.S115707
  33. Michelson D, Allen AJ, Busner J. Once-daily Atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiat. 2002;159:1896-1901.
  34. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal. 2003;168:715-722. 
  35. Kesley D, Sumner C, Casat C. Onse-daily atomoxetine for ADHD including evening and morning behavioral assessment. Scientific Proceeding of the American Academy of Child&Adolescent Psychiatry, Miami, FL, USA; 2003;490-502. 
  36. Block SL, Kelsey D, Coury D, et al. Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing. Clin Pediatr (Phila). 2009;48(7):723-733.  https://doi.org/10.1177/0009922809335321
  37. Kratochvil CJ, Newcorn JH, Arnold LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005;44(9):915-924.  https://doi.org/10.1097/01.chi.0000169012.81536.38
  38. Geller D, Donnelly C, Lopez F, et al. Atomoxetine treatment for pediatric patients with attention-defcit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(9):1119-1127. https://doi.org/10.1097/chi.0b013e3180ca8385
  39. Khoodoruth MAS, Ouanes S, Khan YS. A systematic review of the use of atomoxetine for management of comorbid anxiety disorders in children and adolescents with attention-deficit hyperactivity disorder. Res Dev Disabil. 2022;128:104275. https://doi.org/10.1016/j.ridd.2022.104275
  40. Newcorn JH, Spencer TJ, Biederman J, et al. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005;44(3):240-248.  https://doi.org/10.1097/00004583-200503000-00008
  41. Dell’Agnello G, Maschietto D, Bravaccio C, et al. LYCY Study Group. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Eur Neuropsychopharmacol. 2009;19(11):822-834.  https://doi.org/10.1016/j.euroneuro.2009.07.008

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.